Cresco Labs 미래 성장

Future 기준 확인 0/6

Cresco Labs은 연간 수입과 매출이 각각 61.7%와 1.9% 증가할 것으로 예상되고 EPS는 연간 68.3%만큼 증가할 것으로 예상됩니다.

주요 정보

61.7%

수익 성장률

68.3%

EPS 성장률

Pharmaceuticals 수익 성장	23.7%
매출 성장률	1.9%
향후 자기자본 수익률	n/a
애널리스트 커버리지	Good
마지막 업데이트	12 Nov 2024

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

OTCPK:CRLB.F - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	733	-26	52	70	3
12/31/2025	717	-22	43	76	8
12/31/2024	721	-69	97	130	8
9/30/2024	726	-67	75	100	N/A
6/30/2024	735	-172	59	91	N/A
3/31/2024	747	-155	48	92	N/A
12/31/2023	756	-176	1	59	N/A
9/30/2023	767	-339	-1	65	N/A
6/30/2023	786	-234	-23	50	N/A
3/31/2023	806	-211	-44	25	N/A
12/31/2022	825	-212	-67	19	N/A
9/30/2022	842	-65	-38	53	N/A
6/30/2022	848	-326	-62	34	N/A
3/31/2022	841	-318	-114	-2	N/A
12/31/2021	806	-320	-83	14	N/A
9/30/2021	750	-360	-99	-3	N/A
6/30/2021	687	-73	-74	20	N/A
3/31/2021	573	-105	-25	43	N/A
12/31/2020	463	-102	-97	-8	N/A
9/30/2020	345	-76	-149	-34	N/A
6/30/2020	231	-98	-186	-70	N/A
3/31/2020	168	-64	-185	-57	N/A
12/31/2019	124	-43	-121	-25	N/A
9/30/2019	101	-20	-94	-29	N/A
6/30/2019	78	-14	-67	-20	N/A
3/31/2019	57	-12	-53	-16	N/A
12/31/2018	41	-2	-40	-10	N/A
9/30/2018	28	0	-26	-4	N/A
6/30/2018	19	1	N/A	-7	N/A
3/31/2018	13	1	N/A	-6	N/A
12/31/2017	10	-3	N/A	-5	N/A
12/31/2016	3	-8	N/A	-11	N/A

애널리스트 미래 성장 예측

수입 대 저축률: CRLB.F 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: CRLB.F 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: CRLB.F 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: CRLB.F 의 수익(연간 1.9% ) US 시장( 8.9% 보다 느리게 성장할 것으로 예상됩니다. 8.9% 연간).

고성장 수익: CRLB.F 의 수익(연간 1.9% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: CRLB.F 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

Cresco Labs 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023

Cresco Labs Inc. Provides Earnings Guidance for the Year 2021

Recent updates

Cresco Labs Inc. to Report Q3, 2024 Results on Nov 08, 2024

Cresco Labs Inc. Announces Resignation of Tarik Brooks as Board of Directors

Cresco Labs Inc. Announces CFO Changes

Cresco Labs Inc. to Report Q2, 2024 Results on Aug 08, 2024

Cresco Labs Inc. (CNSX:CL) acquired Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC for $9.8 million.

Cresco Labs Inc. to Report Q1, 2024 Results on May 15, 2024

Cresco Labs Inc., Annual General Meeting, Jun 10, 2024

Cresco Labs Inc. to Report Q4, 2023 Results on Mar 13, 2024

Cresco Labs Inc. Promotes Greg Butler to the Position of President

Cresco Labs Inc. to Report Q3, 2023 Results on Nov 15, 2023

Cresco Labs Inc. completed the acquisition of Sole Licensed Arizona Operation of Cresco Labs Inc.

Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023

Cresco Labs Inc. to Report Q2, 2023 Results on Aug 16, 2023

Cresco Labs Inc. to Report Q1, 2023 Results on May 24, 2023

Combs Enterprises signed a definitive agreements to acquire Certain New York, Illinois, and Massachusetts assets of Cresco Labs Inc. and Columbia Care Inc. for approximately $190 million.

Cresco Labs Inc. to Report Q3, 2022 Results on Nov 15, 2022

Cresco Labs Inc. Announces Resignation of Sidney Dillard from the Board of Director

Aventine Property Group, Inc. acquired Cresco Labs Facility in Brookville, PA for $45 million

Cresco Labs Inc. to Report Q2, 2022 Results on Aug 17, 2022

Cresco Labs Inc. to Report Q1, 2022 Results on May 18, 2022

Cresco Labs Inc., Annual General Meeting, Jun 30, 2022

Cresco Labs Inc. Launches Floracal Farms Brand to Illinois

Cresco Labs Announces Launch of Khalifa Kush Products at Cookies Dispensaries Throughout California

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Laurel Harvest Labs, LLC for $80 million.

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Bay, LLC.

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Bay, LLC for $90 million.

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Cultivate Holdings, LLC.

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Blair Wellness, LLC.

Cresco Labs Inc. Provides Earnings Guidance for the Year 2021

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Cultivate Holdings, LLC for $158 million.

IM Cannabis Corp. (CNSX:IMCC) completed the acquisition of Trichome Financial Corp. (CNSX:TFC) from Cresco Labs Inc., Opaskawayak Cree Nation and others.

Cresco Labs Inc. to Report Q4, 2020 Results on Mar 25, 2021

Cresco Labs Inc. (CNSX:CL) acquired Four dispensaries of Verdant Creations.

Cresco Labs Signs Exclusive Distribution Agreement with California Cannabis Producer, Emerald Family Farms

Cresco Labs Appoints Ty Gent as the New Chief Operating Officer

Cresco Labs Expands High Supply Brand Portfolio to Include 1.0 g and 0.5 mg Live Cartridges Available in California and Illinois

Cresco Labs Inc. has completed a Follow-on Equity Offering in the amount of CAD 158.047776 million.

Cresco Labs Announces Executive Changes

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire all of the issued and outstanding shares of Bluma Wellness Inc. (CNSX:BWEL.U) for approximately $180 million.

Cresco Labs Debuts Deliciously DosedTM Chocolates from its Mindy's Chef Led Artisanal Edibles Brand for the Illinois Recreational Cannabis Market

Cresco Labs Launches Eighth Cannabis Brand, Wonder Wellness Co

Cresco Labs Launches 1.0 g Liquid Live Resin Vape Offering in Illinois and California

Cresco Labs Launches Remedi Cannabis Brand into New York

Cresco Labs Inc. to Report Q3, 2020 Results on Nov 18, 2020

Cresco Labs Bolsters Leadership Team with Three Senior Promotions

Innovative Industrial Properties, Inc. (NYSE:IIPR) completed the acquisition of two properties in Ohio and Michigan from Cresco Labs Inc. (CNSX:CL).

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견